Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03682874 · ClinicalTrials.gov registry record
Identifying Novel Aging Targets for Treatment of Delirium
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 5
- Enrollment target
NCT03682874: Clinical Trial study, sponsored by Wake Forest University Health Sciences.
NCT03682874 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03682874 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The long-term goal of this research program is to improve understanding of the mechanistic link between Alzheimer's disease (AD) neuropathology, acute delirium, and cognitive impairment following acute respiratory failure. In this pilot study, the study team will establish a prospective cohort of older patients with acute respiratory failure and obtain data on delirium duration, AD imaging and CSF biomarkers, and cognitive outcomes following critical illness.
Primary Outcome
gray matter volume
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-10-10 |
| Est. Completion | 2020-02-20 |
Why NCT03682874 stopped before completion
NCT03682874 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03682874 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03682874 about?
NCT03682874 is a clinical study titled "Identifying Novel Aging Targets for Treatment of Delirium". The long-term goal of this research program is to improve understanding of the mechanistic link between Alzheimer's disease (AD) neuropathology, acute delirium, and cognitive impairment following acute respiratory failure. In this pilot study, the study team will establish a prospective cohort of ol...
What is the current status of trial NCT03682874?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2018-10-10. Estimated completion is 2020-02-20.
Who is sponsoring clinical trial NCT03682874?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI